Abstract
Introduction: To retrospectively review metastatic liver cancer (MLC) patients and primary hepatocellular carcinoma (HCC) patients treated with Stereotactic Ablative Body Radiotherapy (SABR) in our institution in the context of a multicentric collaboration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
